Effects of E4/DRSP on self-reported physical and emotional premenstrual and menstrual symptoms: Pooled data from two phase 3 clinical trials
Journal of Obstetrics and Gynaecology Canada（2023）
摘要
To describe the effects of estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg (24/4 regimen) on premenstrual and menstrual symptoms.
更多查看译文
关键词
emotional premenstrual,premenstrual symptoms,e4/drsp,e4/drsp,self-reported
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要